Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionPrincipal Financial Group Inc
Latest Disclosed Ownership455,248 shares
Latest Disclosed Value $ 18,351,046
Principal Financial Group Inc reports 2.51% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 4, 2026 - Principal Financial Group Inc filed a 13F-HR form disclosing ownership of 455,248 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $15,701,504 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 444,092 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 2.51% during the quarter. The current value of the position is $28,789,884 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 455,248 11,156 2.51 18,351 18.75 0.0098
2026-02-02 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 444,092 -77,408 -14.84 15,454 -64.34 0.0079
2025-11-04 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 521,500 -13,949 -2.61 43,342 10.28 0.0219
2025-08-08 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 535,449 4,989 0.94 39,302 -35.14 0.0208
2025-04-28 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 530,460 13,128 2.54 60,589 132.43 0.0340
2025-01-31 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 517,332 21,674 4.37 26,068 13.64 0.0142
2024-10-31 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 495,658 -20,770 -4.02 22,939 36.72 0.0126
2024-07-29 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 516,428 -9,710 -1.85 16,779 26.60 0.0100
2024-04-29 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 526,138 26,452 5.29 13,253 -18.34 0.0078
2024-02-07 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 499,686 -4,807 -0.95 16,230 18.08 0.0103
2023-11-02 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 504,493 -23,308 -4.42 13,745 17.04 0.0099
2023-08-07 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 527,801 -58,458 -9.97 11,744 -7.52 0.0080
2023-05-09 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 586,259 -14,592 -2.43 12,698 4.06 0.0091
2023-02-09 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 600,851 -10,864 -1.78 12,203 -22.19 0.0092
2022-11-09 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 611,715 -45,952 -6.99 15,684 0.28 0.0125
2022-08-10 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 657,667 12,593 1.95 15,640 7.66 0.0116
2022-05-09 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 645,074 -3,635 -0.56 14,527 13.10 0.0058
2022-05-09 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 15,873 357
2022-02-09 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 648,709 -82,815 -11.32 12,844 -10.78 0.0077
2021-11-09 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 731,524 -9,993 -1.35 14,396 -11.75 0.0094
2021-08-10 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 741,517 -4,899 -0.66 16,313 -8.13 0.0105
2021-05-10 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 746,416 2,400 0.32 17,757 -8.77 0.0125
2021-02-23 2020-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 744,016 -14,383 -1.90 19,464 47.45 0.0144
2021-02-08 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 744,016 -14,383 19,464 7,657.4376
2020-11-06 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 758,399 -27,816 -3.54 13,200 -0.18 0.0111
2020-08-05 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 786,215 -11,038 -1.38 13,224 39.51 0.0117
2020-05-12 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 797,253 -31,123 -3.76 9,479 -5.43 0.0105
2020-02-05 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 828,376 3,142 0.38 10,023 -14.07 0.0084
2019-11-13 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 825,234 -13,048 -1.56 11,664 24.79 0.0103
2019-08-12 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 838,282 -62,336 -6.92 9,347 -11.60 0.0084
2019-05-10 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 900,618 -14,475 -1.58 10,574 -13.51 0.0098
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 915,093 -2,976 -0.32 12,226 -5.01 0.0130
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 918,069 111,430 13.81 12,871 1.51 0.0113
2018-08-13 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 806,639 25,939 3.32 12,680 -1.27 0.0117
2018-05-14 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 780,700 22,684 2.99 12,843 -6.19 0.0123
2018-02-12 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 758,016 719,324 1,859.10 13,690 1,732.66 0.0126
2017-11-02 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 38,692 -5,599 -12.64 747 42.83 0.0007
2017-08-08 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 44,291 29,451 198.46 523 220.86 0.0005
2017-05-11 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 14,840 0 0.00 163 50.93 0.0002
2017-02-13 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 14,840 393 2.72 108 14.89 0.0001
2016-11-10 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 14,447 -431 -2.90 94 16.05 0.0001
2016-08-09 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 14,878 2,218 17.52 81 37.29 0.0001
2016-05-10 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 12,660 2,188 20.89 59 13.46 0.0001
2016-02-09 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 10,472 0 0.00 52 33.33 0.0001
2015-11-12 2015-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 10,472 -6,566 -38.54 39 -61.76 0.0001
2015-11-09 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 10,472 39
2015-08-10 2015-06-30 13F CORCEPT THERAPEUTICS COM 218352102 17,038 17,038 0.00 102 0.0002
2015-05-12 2015-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -15,521 -100.00 0 -100.00
2015-02-12 2014-12-31 13F CORCEPT THERAPEUTICS COM 218352102 15,521 -2,727 -14.94 47 -4.08 0.0001
2014-11-13 2014-09-30 13F CORCEPT THERAPEUTICS COM 218352102 18,248 0 0.00 49 -3.92 0.0001
2014-08-12 2014-06-30 13F CORCEPT THERAPEUTICS COM 218352102 18,248 -8,954 -32.92 51 -57.14 0.0001
2014-05-13 2014-03-31 13F CORCEPT THERAPEUTICS COM 218352102 27,202 27,202 4.66 119 190.24 0.0002
2014-02-12 2013-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -25,992 -100.00 0 -100.00
2013-11-05 2013-09-30 13F CORCEPT THERAPEUTICS COM 218352102 25,992 25,992 41 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.